Home Health News Ozempic Shows Potential for Alcohol Addiction in Trial By News Health 1 month Ago Share on FacebookShare on Twitter (MedPage Today) — Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving in adults with alcohol use disorder (AUD), a phase II randomized trial showed. At 9 weeks, semaglutide… Source link : https://www.medpagetoday.com/psychiatry/addictions/114191 Author : Publish date : 2025-02-12 18:44:07 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Transplant Doc's Future in U.S. Uncertain Following Her Deportation to Lebanon By News Health March 18, 2025 This Vaccine Researcher Was Caught in the NIH Funding Cut Crossfire By News Health March 18, 2025 Experts Sound the Alarm on Pricey Skin Substitutes in Wound Care Industry By News Health March 18, 2025 Daily Oral Islatravir and Doravirine Just as Effective as Other ART Regimens for HIV By News Health March 18, 2025 Supranormal EF; Cannabis Use and CVD; Cardiologist's Sex Crime Accusations By News Health March 18, 2025 Future of Canadian Guidelines, Task Force in Doubt By News Health March 18, 2025